Brain purinergic activity linked with depressive symptomatology: hypoxanthine and xanthine in CSF of patients with major depressive disorders.
The purine metabolites hypoxanthine and xanthine were analyzed in cerebrospinal fluid (CSF) of 70 patients with major depressive disorders (diagnosed according to Research Diagnostic Criteria) and, for reference, in 26 nonpsychiatric individuals. In the patient group, levels adjusted by analysis of covariance to same sex, age, height, and weight were univariately and multivariately correlated with both depressive subdiagnoses and individual depressive symptoms. Results indicate that raw CSF levels in depressed patients are significantly correlated with the four variables used in adjustment (for hypoxanthine mainly negatively with height; for xanthine mainly positively with age). Hypoxanthine and xanthine both appear to be linked with the expression of depressive symptomatology: lower levels of hypoxanthine are associated with anger and suicidal tendencies, and higher levels are related to memory disturbance; lower xanthine levels characterize patients with subjective feelings of depression, and in patients with higher levels appetite is poor.
D000328:Adult; D000341:Affective Disorders, Psychotic / Q000134:cerebrospinal fluid*; D000367:Age Factors; D001714:Bipolar Disorder / Q000134:cerebrospinal fluid; D001827:Body Height; D003866:Depressive Disorder / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D007042:Hypoxanthines / Q000134:cerebrospinal fluid*; D008297:Male; D008569:Memory Disorders / Q000134:cerebrospinal fluid; D008875:Middle Aged; D013406:Suicide, Attempted; D014970:Xanthines / Q000134:cerebrospinal fluid*
D007042:Hypoxanthines; D014970:Xanthines